Man Held With 200 Banned Injections Awarded 12-Year Jail Term

Chandigarh : The Chandigarh district court has sentenced a man arrested with 200 banned injections to 12 years of rigorous imprisonment.

The special court judge Rajiv K Beri also imposed a ₹1.20 lakh fine on Yadwinder Singh, who was convicted under Section 22 (c) of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

According to the prosecution, a police team was on patrolling duty near the Electricity Office, in Sector 41, on February 15, 2018 when around 9.30 pm they saw the accused walking towards them with a yellow polythene bag in his right hand. But on spotting the police, he panicked and started walking away.

On frisking him, the cops found 100 injections of buprenorphine (2 ml each) and 100 injections of pheniramine maleate (10 ml each) in his possession. As Singh could not produce any permit for the injections, he was booked under Section 22 of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

The defence counsel submitted that the accused was falsely implicated, and was shown to be arrested from Chandigarh, which was incorrect.

Holding the accused guilty, the court observed, “The nature of offence and recovery of multi-times commercial quantity of 198.8 g of contraband containing buprenorphine from the conscious possession of the convict does not leave any reason with the court to treat him with leniency.”

“It may give the wrong signal to society, thereby, encouraging propagation of delivery and possession of such psychotropic substances which are hazardous, damaging and are potential reasons for spoiling youth,” the court added in its order dated August 23.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad